124 related articles for article (PubMed ID: 28857419)
1. Bisphosphonate use and the risk of breast cancer: a meta-analysis of observational studies.
Ou YJ; Chiu HF; Wong YH; Yang CC; Yang YH
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1286-1295. PubMed ID: 28857419
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate use and the risk of breast cancer: a meta-analysis of published literature.
Liu Y; Zhao S; Chen W; Hu F; Zhu L; Zhang Q; Zhao Y
Clin Breast Cancer; 2012 Aug; 12(4):276-81. PubMed ID: 22622199
[TBL] [Abstract][Full Text] [Related]
4. Association Use of Bisphosphonates with Risk of Breast Cancer: A Meta-Analysis.
Peng R; Liang X; Zhang G; Yao Y; Chen Z; Pan X; Wang J; Liu G
Biomed Res Int; 2020; 2020():5606573. PubMed ID: 33102580
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studies.
Oh YH; Yoon C; Park SM
World J Gastroenterol; 2012 Oct; 18(40):5779-88. PubMed ID: 23155320
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates for breast cancer.
Pavlakis N; Stockler M
Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate use and the risk of endometrial cancer: a meta-analysis of observational studies.
Ou YJ; Chiu HF; Wong YH; Yang YH
Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1107-1115. PubMed ID: 27501339
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer.
Monsees GM; Malone KE; Tang MT; Newcomb PA; Li CI
J Natl Cancer Inst; 2011 Dec; 103(23):1752-60. PubMed ID: 22021667
[TBL] [Abstract][Full Text] [Related]
9. Risk of atypical femoral fracture during and after bisphosphonate use.
Schilcher J; Koeppen V; Aspenberg P; Michaƫlsson K
Acta Orthop; 2015 Feb; 86(1):100-7. PubMed ID: 25582459
[TBL] [Abstract][Full Text] [Related]
10. Oral bisphosphonate use and breast cancer incidence in postmenopausal women.
Chlebowski RT; Chen Z; Cauley JA; Anderson G; Rodabough RJ; McTiernan A; Lane DS; Manson JE; Snetselaar L; Yasmeen S; O'Sullivan MJ; Safford M; Hendrix SL; Wallace RB
J Clin Oncol; 2010 Aug; 28(22):3582-90. PubMed ID: 20567009
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies.
Sun K; Liu JM; Sun HX; Lu N; Ning G
Osteoporos Int; 2013 Jan; 24(1):279-86. PubMed ID: 23052941
[TBL] [Abstract][Full Text] [Related]
12. Alendronate for fracture prevention in postmenopause.
Holder KK; Kerley SS
Am Fam Physician; 2008 Sep; 78(5):579-81. PubMed ID: 18788232
[TBL] [Abstract][Full Text] [Related]
13. Hypertension and breast cancer risk: a systematic review and meta-analysis.
Han H; Guo W; Shi W; Yu Y; Zhang Y; Ye X; He J
Sci Rep; 2017 Mar; 7():44877. PubMed ID: 28317900
[TBL] [Abstract][Full Text] [Related]
14. Oral bisphosphonate use and the risk of female breast, ovarian, and cervical cancer: a nationwide population-based cohort study.
Bae YS; Chang J; Park SM
Arch Osteoporos; 2019 Mar; 14(1):41. PubMed ID: 30888545
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study.
Olszynski WP; Davison KS; Ioannidis G; Brown JP; Hanley DA; Josse RG; Murray TM; Papaioannou A; Sebaldt RJ; Tenenhouse AM; Petrie A; Goldsmith CH; Adachi JD
Osteoporos Int; 2006 Feb; 17(2):217-24. PubMed ID: 15997420
[TBL] [Abstract][Full Text] [Related]
16. Use of bisphosphonates and risk of breast cancer.
Vestergaard P; Fischer L; Mele M; Mosekilde L; Christiansen P
Calcif Tissue Int; 2011 Apr; 88(4):255-62. PubMed ID: 21253712
[TBL] [Abstract][Full Text] [Related]
17. Oral bisphosphonate use associated with a decreased risk of breast cancer.
Dreyfuss JH
CA Cancer J Clin; 2010; 60(6):343-4. PubMed ID: 20959402
[No Abstract] [Full Text] [Related]
18. Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis.
Penning-van Beest FJ; Goettsch WG; Erkens JA; Herings RM
Clin Ther; 2006 Feb; 28(2):236-42. PubMed ID: 16678644
[TBL] [Abstract][Full Text] [Related]
19. Associations between dietary patterns and the risk of breast cancer: a systematic review and meta-analysis of observational studies.
Xiao Y; Xia J; Li L; Ke Y; Cheng J; Xie Y; Chu W; Cheung P; Kim JH; Colditz GA; Tamimi RM; Su X
Breast Cancer Res; 2019 Jan; 21(1):16. PubMed ID: 30696460
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate use and risk of colorectal cancer: a systematic review and meta-analysis.
Bonovas S; Nikolopoulos G; Bagos P
Br J Clin Pharmacol; 2013 Sep; 76(3):329-37. PubMed ID: 23594375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]